Literature DB >> 29388834

The Long Noncoding RNA LnRPT Puts the Brakes on Pulmonary Artery Smooth Muscle Cell Proliferation.

William M Oldham1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29388834      PMCID： PMC5806002          DOI： 10.1165/rcmb.2017-0342ED

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN： 1044-1549            Impact factor:   6.914


× No keyword cloud information.
  15 in total

1.  Imatinib for the treatment of pulmonary arterial hypertension.

Authors:  Hossein A Ghofrani; Werner Seeger; Friedrich Grimminger
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

Review 2.  Pathology of pulmonary hypertension.

Authors:  Rubin M Tuder; John C Marecki; Amy Richter; Iwona Fijalkowska; Sonia Flores
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

Review 3.  Epidemiology and treatment of pulmonary arterial hypertension.

Authors:  Edmund M T Lau; Eleni Giannoulatou; David S Celermajer; Marc Humbert
Journal:  Nat Rev Cardiol       Date:  2017-06-08       Impact factor: 32.419

Review 4.  The metabolic basis of pulmonary arterial hypertension.

Authors:  Gopinath Sutendra; Evangelos D Michelakis
Journal:  Cell Metab       Date:  2014-02-06       Impact factor: 27.287

Review 5.  Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension.

Authors:  Marlene Rabinovitch; Christophe Guignabert; Marc Humbert; Mark R Nicolls
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

6.  Pulmonary hypertension.

Authors:  Sanjiv J Shah
Journal:  JAMA       Date:  2012-10-03       Impact factor: 56.272

Review 7.  Molecular mechanisms of pulmonary arterial remodeling.

Authors:  Patrick Crosswhite; Zhongjie Sun
Journal:  Mol Med       Date:  2014-04-22       Impact factor: 6.354

8.  Notch3 signaling promotes the development of pulmonary arterial hypertension.

Authors:  Xiaodong Li; Xiaoxue Zhang; Robin Leathers; Ayako Makino; Chengqun Huang; Pouria Parsa; Jesus Macias; Jason X-J Yuan; Stuart W Jamieson; Patricia A Thistlethwaite
Journal:  Nat Med       Date:  2009-10-25       Impact factor: 53.440

Review 9.  Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects.

Authors:  Rajiv D Machado; Laura Southgate; Christina A Eichstaedt; Micheala A Aldred; Eric D Austin; D Hunter Best; Wendy K Chung; Nicola Benjamin; C Gregory Elliott; Mélanie Eyries; Christine Fischer; Stefan Gräf; Katrin Hinderhofer; Marc Humbert; Steven B Keiles; James E Loyd; Nicholas W Morrell; John H Newman; Florent Soubrier; Richard C Trembath; Rebecca Rodríguez Viales; Ekkehard Grünig
Journal:  Hum Mutat       Date:  2015-10-12       Impact factor: 4.878

10.  Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.

Authors:  Marius M Hoeper; Robyn J Barst; Robert C Bourge; Jeremy Feldman; Adaani E Frost; Nazzareno Galié; Miguel Angel Gómez-Sánchez; Friedrich Grimminger; Ekkehard Grünig; Paul M Hassoun; Nicholas W Morrell; Andrew J Peacock; Toru Satoh; Gérald Simonneau; Victor F Tapson; Fernando Torres; David Lawrence; Deborah A Quinn; Hossein-Ardeschir Ghofrani
Journal:  Circulation       Date:  2013-02-12       Impact factor: 29.690
View more
  2 in total

Review 1.  Long noncoding RNAs: emerging roles in pulmonary hypertension.

Authors:  Qi Jin; Zhihui Zhao; Qing Zhao; Xue Yu; Lu Yan; Yi Zhang; Qin Luo; Zhihong Liu
Journal:  Heart Fail Rev       Date:  2020-09       Impact factor: 4.214

Review 2.  Epigenetic Targets for Oligonucleotide Therapies of Pulmonary Arterial Hypertension.

Authors:  William Gerthoffer
Journal:  Int J Mol Sci       Date:  2020-12-03       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.